Pulmonx Reports First Quarter 2023 Financial Results

Go back to Pulmonx Reports First Quarter 2023 Financial Results

Pulmonx Corporation (LUNG) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance

May 2, 2023 4:28 PM EDT

Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.42), in-line with the analyst estimate of ($0.42). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.58 million.

GUIDANCE:

Pulmonx Corporation sees FY2023 revenue of $63-65 million, versus the consensus of... More